Sign in
8-K

Current Report

Xilio Therapeutics, Inc. Filed Acc 0001193125-25-051532

Material agreement

  • Item 1.01 Entry into a material definitive agreement

From the SEC's structured data for this filing

Loading d897420d8k.htm…